Risk of stress cardiomyopathy associated with selective serotonin reuptake inhibitors and serotonin and norepinephrine reuptake inhibitors: a real-world pharmacovigilance analysis - Nature.com
Submitted by Anonymous (not verified) on Tue, 07/02/2024 - 07:00
